View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. News
December 14, 2021updated 07 Jan 2022 7:06am

Veeva bolsters clinical suite with Veracity Logic acquisition

Offering quick setup timelines, the Veeva RTSM solution has so far supported more than 175 trials with sites in 60 nations.

Veeva Systems has acquired Cloud software and trial supply management services provider Veracity Logic, bolstering its end-to-end clinical portfolio.

Free Report
img

What’s missing from your IPO industry assessment?

IPO activity all but stopped in 2020, as the investment community grew wary of the effects of COVID-19 on economies. No matter how deserving a business was of flotation, momentum was halted by concerns of when a ‘new normal’ of working patterns and trade would set in. Recently, sentiment has changed. Flotations picked up again during the second half of 2021, and now in 2022 the mood is decidedly optimistic. Business leaders have their eyes on fast rebounding economies, buoyant market indices and the opportunity once again to take their businesses public. As a result, global IPOs are expected to hit back this year. With GlobalData’s new whitepaper, ‘IPOs in Consumer and Retail: 5 must-include elements for your prospectus industry report’, you can explore exactly what is needed in the essential literature. GlobalData’s focus lies in the critical areas to get right:
  • Macroeconomic and demographic environment
  • Consumer context
  • Industry environment
  • Competitive environment
  • Route to market
Interested to learn more about what to include in your IPO Industry Assessment report? Download our free whitepaper.
by GlobalData
Enter your details here to receive your free Report.

The team of Veracity Logic will become part of Veeva to offer software and services, aiding firms to streamline intricate procedures and accelerate clinical trials.

The Veeva RTSM solution provides quick setup timelines and a flexible feature set to fulfil a wide range of randomisation and supply requirements.

The solution has so far supported more than 175 trials with study centres in 60 nations, encompassing a broad range of study designs and complexities in pharmaceutical/biotechnology, medical device and diagnostics areas.

Veeva Systems Vault R&D and Quality vice-president Jim Reilly said: “We are pleased to have the Veracity Logic team join Veeva and look forward to bringing RTSM excellence to our customers.

“This expands Veeva’s clinical offering with flexible and user-friendly RTSM capabilities.”

The company noted that it aims for continuity and transparency for Veeva RTSM clients, as well as partners such as Signant Health, Almac Group, 4G Clinical, S-CLINICA, and Suvoda.

Existing and new clients will be able to incorporate Veeva RTSM into any EDC system and utilise Veeva EDC with any RTSM system.

Veracity Logic founder Steve Zimmerman said: “This acquisition is great for our customers and employees.

“Joining Veeva allows us to scale our solution to a wider market while continuing to deliver customer success.”

Zimmerman will lead Veeva RTSM as general manager while current president David Goldston will resume the role of sales vice-president.

In October this year, Veeva launched the new Veeva Digital Trials Platform that enables execution of trials and data flow between stakeholders, without any interruption.

Related Companies

Free Report
img

What’s missing from your IPO industry assessment?

IPO activity all but stopped in 2020, as the investment community grew wary of the effects of COVID-19 on economies. No matter how deserving a business was of flotation, momentum was halted by concerns of when a ‘new normal’ of working patterns and trade would set in. Recently, sentiment has changed. Flotations picked up again during the second half of 2021, and now in 2022 the mood is decidedly optimistic. Business leaders have their eyes on fast rebounding economies, buoyant market indices and the opportunity once again to take their businesses public. As a result, global IPOs are expected to hit back this year. With GlobalData’s new whitepaper, ‘IPOs in Consumer and Retail: 5 must-include elements for your prospectus industry report’, you can explore exactly what is needed in the essential literature. GlobalData’s focus lies in the critical areas to get right:
  • Macroeconomic and demographic environment
  • Consumer context
  • Industry environment
  • Competitive environment
  • Route to market
Interested to learn more about what to include in your IPO Industry Assessment report? Download our free whitepaper.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Clinical Trials Arena